5th Oct 2022 9:06 am |
RNS |
Second Price Monitoring Extn |
5th Oct 2022 9:00 am |
RNS |
Price Monitoring Extension |
30th Sep 2022 4:41 pm |
RNS |
Second Price Monitoring Extn |
30th Sep 2022 4:35 pm |
RNS |
Price Monitoring Extension |
30th Sep 2022 7:00 am |
RNS |
Half-year Report |
26th Sep 2022 7:00 am |
RNS |
Marla Dubinsky a recipient of 2022 Sherman Prize |
22nd Sep 2022 7:00 am |
RNS |
Notice of Results and Investor Presentation |
1st Aug 2022 7:00 am |
RNS |
Appointment of Chief Financial Officer |
19th Jul 2022 7:00 am |
RNS |
Directorate Changes |
27th Jun 2022 2:47 pm |
RNS |
Result of AGM and voting results |
23rd Jun 2022 7:00 am |
RNS |
Directorate Change |
25th May 2022 12:00 pm |
RNS |
Posting of Annual Report & Accounts |
10th May 2022 7:01 am |
RNS |
Investor Presentation |
10th May 2022 7:00 am |
RNS |
Final Results |
7th Apr 2022 7:00 am |
RNS |
Notice of Results |
28th Feb 2022 7:00 am |
RNS |
Direct to Consumer market launch in New York |
21st Jan 2022 7:00 am |
RNS |
Appointment of Chief Financial Officer |
17th Jan 2022 7:00 am |
RNS |
Clinical research update on GRITT(tm) methodology |
4th Jan 2022 7:00 am |
RNS |
Directorate Change |
20th Dec 2021 3:44 pm |
RNS |
Issue of Equity |
14th Dec 2021 7:00 am |
RNS |
Trading update |
22nd Sep 2021 7:00 am |
RNS |
Half-year Report |
16th Sep 2021 7:00 am |
RNS |
New Partnership Agreement & Licensed Clinical Team |
9th Sep 2021 7:00 am |
RNS |
Notice of Results |
23rd Aug 2021 7:00 am |
RNS |
First Demonstration Programme Contract |
11th Jun 2021 4:40 pm |
RNS |
Second Price Monitoring Extn |
11th Jun 2021 4:35 pm |
RNS |
Price Monitoring Extension |
2nd Jun 2021 3:50 pm |
RNS |
Holding(s) in Company |
28th May 2021 2:05 pm |
RNS |
Second Price Monitoring Extn |
28th May 2021 2:00 pm |
RNS |
Price Monitoring Extension |
28th May 2021 7:00 am |
RNS |
Admission to AIM and First Day of Dealings |